Their group reported the protective effect of intraperitoneal injection of the TLR4 or TLR7/8 agonist 24 h prior to the initiation of sepsis, resulting in increased survival and reduced bacteremia via enhanced peritoneal neutrophil recruitment [7]. This evidence concerns the gene TLR4 and bacterial infectious disease with sepsis.